Chlorpromazine HydrochlorideThird Party Manufacturing in India

Chlorpromazine Hydrochloride exerts its antipsychotic effects primarily through high-affinity antagonism of dopamine D2 receptors in the mesolimbic pathway of the brain. By competitively blocking dopamine binding at postsynaptic D2 receptors, Chlorpromazine reduces the excessive dopaminergic neurotransmission that is believed to underlie positive psychotic symptoms such as hallucinations, delusions, and thought disorder. Unlike second-generation antipsychotics, Chlorpromazine has a broad receptor profile that extends well beyond dopamine blockade. It is a potent antagonist at histamine H1 receptors, which accounts for its strong sedative and antiemetic properties; at alpha-1 adrenergic receptors, leading to vasodilation and orthostatic hypotension; and at muscarinic M1 receptors, responsible for anticholinergic side effects such as dry mouth, blurred vision, and constipation. It also blocks serotonin 5-HT2A receptors, which contributes to its mood-stabilising and antiemetic actions. This multi-receptor activity explains both the therapeutic breadth of Chlorpromazine and its diverse side-effect profile. The drug has a long elimination half-life of approximately 30 hours, allowing for once-daily maintenance dosing in stabilised patients.

Therapeutic Uses

Chlorpromazine Hydrochloride is prescribed for the treatment of:

• Schizophrenia: First-line therapy for acute psychotic episodes and maintenance treatment for chronic schizophrenia, particularly effective for positive symptoms.
• Bipolar Disorder: Used in the management of acute manic episodes, often as part of combination therapy with mood stabilisers.
• Nausea and Vomiting: Potent antiemetic effect mediated through blockade of dopamine receptors in the chemoreceptor trigger zone.
• Intractable Hiccups: One of the few pharmacological options for persistent hiccups that do not respond to conventional measures.
• Acute Agitation: Rapid tranquillisation in psychiatric emergencies via intramuscular administration due to its strong sedative properties.
• Preoperative Anxiety: Used for its anxiolytic and sedative effects before surgical procedures.

Why Manufacturers Choose Chlorpromazine Hydrochloride

Chlorpromazine Hydrochloride remains a cornerstone antipsychotic in many developing and middle-income countries, including India, due to its proven efficacy, extensive clinical history, and low cost of therapy. The molecule is included in the WHO Model List of Essential Medicines, confirming its public health importance. For contract manufacturers, Chlorpromazine offers steady institutional demand from government hospitals, psychiatric care centres, and public health programmes. Indian manufacturers benefit from well-established API supply chains and the ability to produce multiple dosage forms including tablets, injections, and syrups within WHO-GMP certified facilities. The consistent procurement volumes from state tenders and the expanding psychiatric care infrastructure in India create reliable demand for Chlorpromazine Hydrochloride third-party manufacturing partnerships.